Stay updated with breaking news from Early Access Programs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Clinigen launches ‘What is Possible?’ campaign to accelerate access to medicines on Rare Disease Day With over 7,000 rare diseases that impact over 300 million people globally, just 5% of rare diseases have a licensed treatment* LONDON, UK, 29 February 2024 – Clinig...
Investegate announcements from Placing and Subscription
The following is a round-up of earnings of London-listed companies, issued on Wednesday and not separately reported by Alliance News: ---------- ASA International Group PLC - Weybridge, Surrey-based...
Quoin announced dosing of first patient in double blinded clinical study to evaluate QRX003 for Netherton SyndromeQuoin announced initiation of a second...
COVA study met primary end point with 44% significant reduction in the risk of respiratory failure or early deathFiling for Early Access Programs to Sarconeos (BIO101) is being initated while preparing